Performing colonic mast cell counts in patients with chronic diarrhea of unknown etiology has limited diagnostic use

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 2, 2015, Pages 225-232

  Sethi, Aisha ^a   Jain, Dhanpat ^b   Roland, Bani Chander ^c   Kinzel, Jason ^b   Gibson, Joanna ^b   Schrader, Ronald ^a   Hanson, Joshua Anspach ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BIOPSY; CELL COUNT; CHRONIC DISEASE; COLON; COLONOSCOPY; DEMOGRAPHY; DIARRHEA; FEMALE; HUMAN; INTESTINE MUCOSA; MALE; MAST CELL; MASTOCYTOSIS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL COUNT; CHRONIC DISEASE; COLON; COLONOSCOPY; DEMOGRAPHY; DIARRHEA; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; YOUNG ADULT;

EID: 84921484238     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0594-OA     Document Type: Article

References (22)

1. Clinical Practice Committee of the American Gastroenterological Association (AGA); Practice Economics Committee of the AGA. American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116(6):1461-1463.
2. Sperber AD, Shvartzman P, Friger M, Fich A. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol. 2007;19(6): 441-447.
3. Jakate S, Demeo M, John R, Tobin M, Keshavarzian A. Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med. 2006;130(3):362-367.
4. Akhavein MA, Patel NR, Muniyappa PK, Glover SC. Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract. 2012;2012:950582. doi: 10.1155/2012/950582.
5. Ramsay DB, Stephen S, Borum M, Voltaggio L, Doman DB. Mast cells in gastrointestinal disease. Gastroenterol Hepatol (N Y). 2010;6(12):772-777.
6. Thonhofer R, Siegel C, Trummer M, Langner C. Mastocytic enterocolitis as a rare cause of chronic diarrhea in a patient with rheumatoid arthritis. Wien Klin Wochenschr. 2011;123(9-10):297-298.
7. Bradesi S, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sci. 2001; 68(9):1047-1056.
8. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136(6):2003-2014.
9. Park CH, Joo YE, Choi SK, Rew JS, Kim SJ, Lee MC. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. J Korean Med Sci. 2003;18(2):204-210.
10. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77(4): 1033-1079.
11. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126(3):693-702.
12. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil. 2000;12(5):449-457.
13. Stoyanova II, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 2002;104(2):185-192.
14. He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol. 2004;10(3):309-318.
15. Minocha A, Thomas C, Omar R. Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice. Dig Dis Sci. 1995;40(8):1757-1762.
16. Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 1996;28(1):1-13.
17. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38(9):1590-1595.
18. Talley NJ, Butterfield JH. Mast cell infiltration and degranulation in colonic mucosa in the irritable bowel syndrome. Am J Gastroenterol. 1996;91(8):1675-1676.
19. Irvine E, Gaebel K, Driman D, Riddell R, Collins S. Mucosal mast cells (MMC) numbers are normal in biopsies of patients with irritable bowel syndrome (IBS). Gastroenterology. 1995;108(4)(suppl 2):A620. AGA Abstracts. American Gastroenterology Association Annual Meeting. doi : 10.1016/ 0016-5085(95)26793-x.
20. Chang F, Anderson S. Clinical and pathological features of eosinophilic oesophagitis: a review. Pathology. 2008;40(1):3-8.
21. Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilic esophagitis in adults: Distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19(1):90-96.
22. Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103(2):435-442.